Litcius/Paper detail

A pro-oxidant combination of resveratrol and copper reduces chemotherapy-related non-haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single-arm study (RESCU III study)

Vikas Ostwal, Anant Ramaswamy, Prabhat Bhargava, Sujay Srinivas, Sarika Mandavkar, Deepali Chaugule, Zoya Peelay, Akshay Baheti, Harshali Tandel, Vishal Jadhav, Sushma Shinde, Shraddha Jadhav, Vikram Gota, Indraneel Mittra

2022Medical Oncology31 citationsDOI

Topics & Concepts

Common Terminology Criteria for Adverse EventsToxicityMedicineChemotherapyDocetaxelInternal medicineCancerVomitingGastroenterologyPharmacologyOncologySurgeryChemotherapy-related skin toxicityPARP inhibition in cancer therapyCancer Diagnosis and Treatment
A pro-oxidant combination of resveratrol and copper reduces chemotherapy-related non-haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single-arm study (RESCU III study) | Litcius